2002
DOI: 10.1002/14651858.cd002804
|View full text |Cite
|
Sign up to set email alerts
|

Second-line chemotherapy for non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 62 publications
0
9
0
Order By: Relevance
“…2004) included a definition. Bonfill et al. (2001) used a definition that was exclusive, rather than inclusive, stating that best supportive care was ‘.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…2004) included a definition. Bonfill et al. (2001) used a definition that was exclusive, rather than inclusive, stating that best supportive care was ‘.…”
Section: Resultsmentioning
confidence: 99%
“…Alberti et al (1995) No. Bonfill et al (2001) BSC was defined as any appropriate therapy (including radiotherapy) that did not include chemotherapy. Chu et al (2005) No.…”
Section: Randomised Controlled Trialsmentioning
confidence: 99%
See 1 more Smart Citation
“…Docetaxel monotherapy was the accepted standard of care for more than a decade for second-line therapy in unselected patients with NSCLC relapsing after first-line therapy [1,2]. However, docetaxel is associated with numerous haematological and non-haematological adverse events, including diarrhoea, nausea, vomiting, anaemia, neutropenia and neutropenic sepsis (NS; also known as febrile neutropenia) [3]. Although docetaxel monotherapy remains the benchmark by which other second-line treatments are evaluated, a number of newer therapies for NSCLC have demonstrated benefit in terms of endpoints such as progression-free survival, overall survival and toxicity when used either alone or in combination [2,4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Chemotherapy is widely used to treat lung cancer either alone or, combined with surgical resection and radiotherapy [2]. However the 5-year survival rate only reaches 18% [3].…”
Section: Introductionmentioning
confidence: 99%